Multidisciplinary Treatment of Stage III ALK+ NSCLC With Neoadjuvant Alectinib and Chemotherapy
Clinical trial NCT07573696 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07573696
- Sponsor
- Wen-zhao ZHONG
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-15
- Primary completion
- 2030-02-08
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.